Abstract
IntroductionPrecancerous cervical lesion is significantly a health problem globally. Thus, screening targeting women between the ages of 17-60 is being undertaken in developing countries, including Cameroon. Over 50% (7.8 per 100,000) women die of cervical cancer every year. This study was to determine the prevalence of precancerous cervical lesion, the age demography and access the risk factor.MethodsA hospital-based cross-sectional study was conducted from August 09th to October 17th 2017. A total of 60 women participated, and were screened for precancerous cervical lesion. Data were collected by using a questionnaire. Visual inspection with acetic acid and visual inspection with Lugol’s iodine was applied for the screening. SPSS version 16.0 was used for data entry and analysis. Logistic regression analysis was fitted and odds ratios with 95% confidence intervals and p-values were computed to identify factors associated with precancerous cervical cancer lesion.ResultsOut of 60 study participants, 2(3.33%) were found to be positive for precancerous cervical cancer lesion.ConclusionThe prevalence of precancerous cervical lesion in women that consulted at the Mezam polyclinic is high.
Highlights
Women in Africa as well as those residing in Cameroon, suffer a disproportionate rate of cervical cancer morbidity and mortality [1]
The difference of prevalence of the precancerous lesions of the uterine cervix from one country to another is mainly due to the existence and consistency of screening programs and management options implemented in these countries
In Botswana, a cervical cancer screening program of 2,175 women based on Visual inspection with acetic acid (VIA) found that the proportion of precancerous cervical cancer lesion confirmed by histology was 15.2% [18]
Summary
Women in Africa as well as those residing in Cameroon, suffer a disproportionate rate of cervical cancer morbidity and mortality [1]. Human papillomavirus (HPV) leads to cervical cancer. In Cameroon, cervical cancer screening services and testing for HPV are mostly available at private health clinics and some government hospitals in the urban areas. Majority of the cervical cancer victims are poor rural women who are unable to access screening and testing services [2, 3]. Those who screen are unable to return for follow-up or complete treatment due to: inadequate medical advice, lack of awareness of the significance of their symptoms, cultural and religious factors as well as the lack of finances to pay for the services
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
